A Patient of Chronic Kidney Disease Receiving Haemodialysis

Authors: Saleha Sadeeqa, Tania Munawar

1 Institute of Pharmacy, Lahore College for Women University Lahore Pakistan
2 Lahore College for Women University Lahore Pakistan

Volume 23 | Issue 4

Published: October 27, 2026

Abstract

Chronic kidney disorder is the progressive, irreversible damage to the kidney functions, as a result of which the renal replacement therapy is given in the form of dialysis (haemodialysis or peritoneal dialysis )and renal transplantation depending upon the patient condition, along with the medication therapy and lifestyle modifications. The focus of this study is to check the pharmaceutical care given to the patient of Chronic kidney disease on heamodialysis and the compliance of the patient to the therapy. The outcome of the therapy was to improve the patient’s quality of life, slow down the progression of the disease and to avoid the complications associated with the therapy.

Keywords: Chronic kidney disease (CKD), Haemodialysis, Pharmaceutical care, Quality of life.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF